삼성서울병원

Ko En

병리과 안수민 교수

진료분야
소화기병리
진료일정 03 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2018.08 성균관대학교 대학원 의학과 박사
2014.02 성균관대학교 대학원 의학과 석사
2008.02 이화여자대학교 의학과 학사

경력

경력
2023.03 ~현재 성균관대학교 의과대학 병리학교실 조교수
2022.03 ~ 2023.02 삼성서울병원 병리과 전임대우조교수
2020.03 ~ 2022.02 삼성서울병원 병리과 진료조교수
2017.09 ~ 2020.02 분당서울대병원 병리과 임상조교수
2017.03 ~ 2017.08 분당서울대병원 병리과 진료조교수
2016.03 ~ 2017.02 이화의료원 병리과 전임의
2015.03 ~ 2016.02 삼성서울병원 병리과 전임의
2014.03 ~ 2015.02 Cancer Research UK, Cambridge Institute, University of Cambridge Visiting Fellow
2010.03 ~ 2014.02 삼성서울병원 병리과 전공의
2008.03 ~ 2009.02 삼성서울병원 인턴
  • YONSEI MED J 2023 10.3349/ymj.2023.0161 The First Korean Adult Case of Progressive Familial Intrahepatic Cholestasis Type 7 with Novel USP53 Splicing Variants by Next Generation Sequencing Ahn, S; Choi, J; Jeong, SH
    View PubMed
  • HISTOPATHOLOGY 2023 10.1111/his.15081 Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality Na, HY; Kim, JH; Kim, H; Cho, JY; Han, HS; Jang, ES; Kim, JW; Jeong, SH; Heo, J; Kim, JW; Kim, JW; Ahn, S
    View PubMed
  • CANCER MED-US 2023 10.1002/cam4.6472 Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer Shin, M; Ahn, S; Jung, J; Hyung, S; Kim, KM; Kim, ST; Kang, WK; Lee, J
    View PubMed
  • J PATHOL 2023 10.1002/path.6134 PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma Choi, S; Kim, H; Heo, YJ; Kang, SY; Ahn, S; Lee, JY; Kim, KM
    View PubMed
  • ANN DERMATOL 2023 10.5021/ad.21.060 Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum Lee, HC; Kwon, Y; Kim, ES; Ahn, S; Choe, YH; Kim, MJ
    View PubMed
  • CANCERS 2023 10.3390/cancers15061656 Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia Oh, SE; Park, S; Ahn, S; An, JY; Lee, JH; Sohn, TS; Bae, JM; Choi, MG
    View PubMed
  • J GASTRIC CANCER 2023 10.5230/jgc.2023.23.e7 A Standardized Pathology Report for Gastric Cancer: 2nd Edition Park, YS; Kook, MC; Kim, BH; Lee, HS; Kang, DW; Gu, MJ; Shin, OR; Choi, Y; Lee, W; Kim, H; Song, IH; Kim, KM; Kim, HS; Kang, G; Park, DY; Jin, SY; Kim, JM; Choi, YJ; Chang, HK; Ahn, S; Chang, MS; Han, SH; Kwak, Y; Seo, AN; Lee, SH; Cho, MY
    View PubMed
  • ELIFE 2022 10.7554/eLife.78636 Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors Kang, M; Na, HY; Ahn, S; Kim, JW; Lee, S; Ahn, S; Lee, JH; Youk, J; Kim, HT; Kim, KJ; Suh, KJ; Lee, JS; Kim, SH; Kim, JW; Kim, YJ; Lee, KW; Yoon, YS; Kim, JH; Chung, JH; Han, HS; Lee, JS
    View PubMed
  • PATHOL ONCOL RES 2022 10.3389/pore.2022.1610697 MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer Ko, J; Jung, J; Kim, ST; Hong, JY; Park, S; Park, JO; Park, YS; Lim, HY; Ahn, S; Kim, KM; Kang, WK; Lee, J
    View PubMed
  • DIAGNOSTICS 2022 10.3390/diagnostics12102355 Peritoneal Seeding Is More Common in Gastric Cancer Patients with FGFR2 Amplification or High Tumor Mutation Burden Kim, H; Park, S; Kang, SY; Ahn, S; Kim, KM
    View PubMed
  • PATHOL RES PRACT 2022 10.1016/j.prp.2022.154108 Gastric cancer with Epstein-Barr virus heterogeneity: Evaluation of the frequency, clinicopathologic features, and genomic profiles Kim, HN; Ahn, S; Kim, KM
    View PubMed
  • PATHOL RES PRACT 2022 10.1016/j.prp.2022.153874 Comparative analysis of microsatellite instability by next-generation sequencing, MSI PCR and MMR immunohistochemistry in 1942 solid cancers Kang, SY; Kim, DG; Ahn, S; Ha, SY; Jang, KT; Kim, KM
    View PubMed
  • BIOMEDICINES 2022 10.3390/biomedicines10030543 Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches Choi, S; Park, S; Kim, H; Kang, SY; Ahn, S; Kim, KM
    View PubMed
  • CANCER GENOM PROTEOM 2022 10.21873/cgp.20307 High Frequency of Juxtamembrane Domain ERBB2 Mutation in Gastric Cancer Park, S; Ahn, S; Kim, DG; Kim, H; Kang, SY; Kim, KM
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.792340 The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers Kim, HR; Ahn, S; Jo, H; Kim, H; Hong, J; Lee, J; Lim, HY; Kang, WK; Kim, ST
    View PubMed
  • CLIN TRANSL ONCOL 2021 10.1007/s12094-021-02714-6 Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer Kim, H; Heo, YJ; Cho, YA; Kang, SY; Ahn, S; Kim, KM
    View PubMed
  • CANCERS 2021 10.3390/cancers13174454 Clinical Impact of Unexpected Para-Aortic Lymph Node Metastasis in Surgery for Resectable Pancreatic Cancer Lee, HK; Yoon, YS; Han, HS; Lee, JS; Na, HY; Ahn, S; Park, J; Jung, K; Jung, JH; Kim, J; Hwang, JH; Lee, JC
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-98857-1 Deep learning-based virtual cytokeratin staining of gastric carcinomas to measure tumor-stroma ratio Hong, Y; Heo, YJ; Kim, B; Lee, D; Ahn, S; Ha, SY; Sohn, I; Kim, KM
    View PubMed
  • J CANCER RES CLIN 2021 10.1007/s00432-021-03781-6 The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors Kim, H; Ahn, S; Kim, H; Hong, JY; Lee, J; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, KM; Kim, ST
    View PubMed
  • FRONT IMMUNOL 2021 10.3389/fimmu.2021.698721 Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity Kim, ES; Kim, D; Yoon, Y; Kwon, Y; Park, S; Kim, J; Ahn, KM; Ahn, S; Choe, YH; Kim, YJ; Kim, MJ
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e29 Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability Ahn1, S; Woo, JW; Kim, H; Cho, EY; Kim, A; Kim, JY; Kim, C; Lee, HJ; Lee, JS; Bae, YK; Kwon, Y; Kim, WS; Park, SY
    View PubMed
  • AM J SURG PATHOL 2021 10.1097/PAS.0000000000001651 Gastric Inverted Polyps-Distinctive Subepithelial Lesions of the Stomach Clinicopathologic Analysis of 12 Cases With an Emphasis on Neoplastic Potential Kim1, JY; Ahn, S; Kim, KM; Chang, SH; Kim, HS; Lee, JH; Kim, JJ; Sohn, TS; Kang, HJ; Joo, M
    View PubMed
  • MODERN PATHOL 2021 10.1038/s41379-021-00823-9 PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy Ahn1, S; Kim, KM
    View PubMed
  • PATHOL ONCOL RES 2021 10.3389/pore.2021.604600 The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness Park1, H; Lee, Y; Lee, K; Lee, H; Yoo, JE; Ahn, S; Park, YN; Kim, H
    View PubMed
  • CANCERS 2020 10.3390/cancers12082128 The Clinicopathological and Prognostic Significance of Nrf2 and Keap1 Expression in Hepatocellular Carcinoma Lee1, K; Kim, S; Lee, Y; Lee, H; Lee, Y; Park, H; Nahm, JH; Ahn, S; Yu, SJ; Lee, K; Kim, H
    View PubMed
  • PATHOL RES PRACT 2020 10.1016/j.prp.2019.152734 Correlation between RICTOR overexpression and amplification in advanced solid tumors Bang1, H; Ahn, S; Kim, EJ; Kim, ST; Park, H; Lee, J; Kim, KM
    View PubMed

해당하는 결과가 없습니다.